Clincosm LogoSign in Get a demo

Haemophilia A

Showing 1 - 25 of 73
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Haemophilia A, Haemophilia A With Inhibitors Trial in Worldwide (NNC0365-3769 (Mim8) PPX)

Not yet recruiting
  • Haemophilia A
  • Haemophilia A With Inhibitors
  • NNC0365-3769 (Mim8) PPX
  • Los Angeles, California
  • +27 more
May 12, 2023

Haemophilia A Trial in China (turoctocog alfa pegol (N8-GP))

Completed
  • Haemophilia A
  • turoctocog alfa pegol (N8-GP)
  • Beijing, Beijing, China
  • +9 more
Feb 2, 2023

Register of Patients With haEmophilia A tReated With Afstyla®

Active, not recruiting
  • Haemophilia A
  • Afstyla®
  • Brest, France
  • +16 more
Feb 1, 2023

From the EUHASS Registry on Turoctocog Alfa Pegol

Enrolling by invitation
  • Haemophilia A
  • Turoctocog alfa pegol
  • Søborg, Denmark
    Novo Nordisk Investigational Site
Jan 24, 2023

Haemophilia A Trial in Berlin (NNC0365-3769 (Mim8))

Recruiting
  • Haemophilia A
  • NNC0365-3769 (Mim8)
  • Berlin, Germany
    Novo Nordisk Investigational Site
Jan 24, 2023

Haemophilia A, Haemophilia A With Inhibitors Trial in Worldwide (Mim8)

Not yet recruiting
  • Haemophilia A
  • Haemophilia A With Inhibitors
  • Los Angeles, California
  • +15 more
Jan 19, 2023

Turoctocog Alfa in Haemophilic Italian Patients: Protection and

Enrolling by invitation
  • Haemophilia A
  • Turoctocog alfa
  • Milano, MI, Italy
  • +9 more
Jan 12, 2023

Health of Joints in People With Haemophilia Taking Medicine

Not yet recruiting
  • Haemophilia A
  • (no location specified)
Jan 1, 2023

Congenital Bleeding Disorder, Haemophilia A Trial in Worldwide (Turoctocog alfa pegol)

Completed
Has Results
  • Congenital Bleeding Disorder
  • Haemophilia A
  • Turoctocog alfa pegol
  • Phoenix, Arizona
  • +66 more
Dec 20, 2022

Following Males With Haemophilia A on Prophylaxis With Esperoct®

Enrolling by invitation
  • Haemophilia A
  • Turoctocog alfa pegol (N8-GP)
  • Wien, Austria
  • +22 more
Nov 11, 2022

(Use-results Surveillance) With Esperoct®

Enrolling by invitation
  • Haemophilia A
  • Turoctocog alfa pegol
  • Fukuoka, Japan
  • +14 more
Nov 8, 2022

Utilisation of Nuwiq, Octanate and Wilate in Previously

Recruiting
  • Haemophilia A
    • Las Vegas, Nevada
    • +33 more
    Jul 7, 2022

    Real-world Usage and Effectiveness of Elocta and Alprolix in

    Completed
    • Haemophilia A
    • Haemophilia B
    • Berlin, Germany
    • +21 more
    May 3, 2022

    Haemophilia A, Haemophilia A With Inhibitors Trial in Worldwide (NNC0365-3769 (Mim8))

    Recruiting
    • Haemophilia A
    • Haemophilia A With Inhibitors
    • NNC0365-3769 (Mim8)
    • Phoenix, Arizona
    • +85 more
    Mar 23, 2022

    Congenital Bleeding Disorder, Haemophilia A Trial in Worldwide (turoctocog alfa pegol)

    Active, not recruiting
    • Congenital Bleeding Disorder
    • Haemophilia A
    • turoctocog alfa pegol
    • Phoenix, Arizona
    • +69 more
    Mar 18, 2022

    Following People With Haemophilia A and B, With or Without

    Completed
    • Haemophilia A
    • +3 more
    • No treatment given
    • Los Angeles, California
    • +142 more
    Nov 22, 2021

    Haemophilia A Trial in Worldwide (Recombinant Factor VIII (Kovaltry, BAY81-8973))

    Completed
    Has Results
    • Haemophilia A
    • Recombinant Factor VIII (Kovaltry, BAY81-8973)
    • New Orleans, Louisiana
    • +42 more
    Nov 16, 2021

    Haemostasis, Haemophilia A Trial in Worldwide (Concizumab, Turoctocog alfa)

    Completed
    Has Results
    • Haemostasis
    • Haemophilia A
    • Los Angeles, California
    • +30 more
    Nov 15, 2021

    Novoeight®/NovoEight® in Mexican Haemophilia A Patients

    Completed
    • Congenital Bleeding Disorder
    • Haemophilia A
    • turoctocog alfa
    • Monterrey, Nuevo León, Mexico
      Novo Nordisk Investigational Site
    Nov 12, 2021

    NovoEight® During Long-term Treatment of Haemophilia A in Japan

    Completed
    • Congenital Bleeding Disorder
    • Haemophilia A
    • turoctocog alfa
    • Suginami-ku, Tokyo, Japan
    • +1 more
    Nov 12, 2021

    Success of Inhibitor Elimination Using Individualized

    Recruiting
    • Haemophilia A
      • Mörfelden-Walldorf, Germany
        Haemophilia centre Rhine Main (HZRM)
      Aug 31, 2021

      Haemophilia A Trial in Colombia, Germany, Poland (Optivate 500IU)

      Terminated
      Has Results
      • Haemophilia A
      • Optivate 500IU
      • Barranquilla, Colombia
      • +3 more
      Jul 21, 2021

      Congenital Bleeding Disorder, Haemophilia A Trial in Worldwide (turoctocog alfa)

      Completed
      Has Results
      • Congenital Bleeding Disorder
      • Haemophilia A
      • turoctocog alfa
      • Phoenix, Arizona
      • +68 more
      Nov 26, 2020

      Congenital Bleeding Disorder, Haemophilia A Trial in Worldwide (turoctocog alfa pegol)

      Completed
      Has Results
      • Congenital Bleeding Disorder
      • Haemophilia A
      • turoctocog alfa pegol
      • Phoenix, Arizona
      • +92 more
      Nov 3, 2020

      Congenital Bleeding Disorder, Haemophilia A Trial in Worldwide (turoctocog alfa pegol)

      Completed
      Has Results
      • Congenital Bleeding Disorder
      • Haemophilia A
      • turoctocog alfa pegol
      • Phoenix, Arizona
      • +50 more
      Nov 3, 2020